Al Jalila Foundation, the philanthropic arm of Dubai Health, announced that the names of 18 donors will be added to 19 sections and facilities at the Hamdan Bin Rashid Cancer Hospital, in recognition of their generous contributions to the construction of Dubai’s first fully integrated comprehensive cancer care facility.

The announcement was made during an honoring ceremony, which was organized recently by Al Jalila Foundation at the construction site of the hospital, in the presence of His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors.

The event was also attended by Her Excellency Dr. Raja Easa Al Gurg, member of the Dubai Health Board of Directors, Chairperson of the Al Jalila Foundation Board of Directors and Chair of the Hamdan Bin Rashid Cancer Hospital Steering Committee; Dr. Amer Sharif, CEO of Dubai Health, and Dr. Amer Al Zarooni, CEO of Al Jalila Foundation.

Donor Names
The list of donors whose names will be added to the hospital’s sections and facilities includes: Abdul Rahim Mohammed Belghozooz Al Zarooni, Dubai Electricity and Water Authority (DEWA), Dubai Chambers, AWQAF Dubai, Dubai Integrated Economic Zones Authority, Al Ansari Exchange, Sharaf Group, Al Sayyah Group, AW Rostamani Group, Chalhoub Group, Easa Saleh Al Gurg Charity Foundation, Abdulla Hassan Al Rostamani’s family, Abdulsalam Al Rafi’s family, Innovo, Mohammed Ibrahim Obaidullah, Seddiqi Holding, Dr. Wael Al Mahmeed, and Eissa Abdullah Abdullaziz Al Othman Endowment.

Dr. Amer Al Zarooni expressed his sincere appreciation to all donors for their generous support of the Hamdan Bin Rashid Cancer Hospital project, emphasizing that their contributions embody the highest values of giving and social responsibility and serve as a cornerstone in building an advanced healthcare system.

Dr. Al Zarooni noted that Al Jalila Foundation has designated 30 sections and facilities within the hospital to additionally carry the names of donors as a mark of recognition. Each donor’s name will be added to the section or facility they helped fund, acknowledging their strategic role in supporting this humanitarian project, which represents a landmark addition to Dubai’s healthcare infrastructure and lay the foundation for a better future in cancer care.

The donors expressed their pride in having their names associated with facilities and sections at Hamdan Bin Rashid Cancer Hospital. They emphasized that giving is both a social responsibility and a noble humanitarian mission through which they aim to make a real difference in patients’ lives and help enhance Dubai’s healthcare system.

Abdul Rahim Belghozooz Al Zarooni said he was proud to contribute to the construction of Hamdan Bin Rashid Cancer Hospital. He shared that his contribution stems from his strong belief that philanthropy is a social responsibility. He added, “To every cancer patient, I want you to know you are not alone. This hospital was built with you in mind, to provide advanced care and renewed hope for recovery.”

His Excellency Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA), affirmed that the late Sheikh Hamdan bin Rashid Al Maktoum left a profound humanitarian legacy marked by generosity and support for the health sector. His patronage of medical research, health innovation, and charitable work continues to inspire. DEWA’s contribution to the Hamdan Bin Rashid Cancer Hospital project reflects its commitment to preserving the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum and aligns with its corporate social responsibility strategy. This initiative exemplifies the Authority’s national commitment to enhancing quality of life, upholding noble humanitarian values, supporting the healthcare sector, and fostering social solidarity, all in alignment with the Sustainable Development Goals and the UAE’s leadership vision for a cohesive and healthy society.

His Excellency Mohammad Ali Rashed Lootah, President and CEO of Dubai Chambers, noted that their support for the Hamdan Bin Rashid Cancer Hospital project reflects their commitment to empowering the business community to actively advance vital sectors, particularly healthcare, and to strengthen Dubai’s competitiveness and leadership as a global medical and healthcare hub. The Chambers added that the initiative truly exemplifies the public-private partnership.

Mohammad Ali Al Ansari, Chairman of Al Ansari Exchange, emphasized that their contribution exemplifies their deep belief in the importance of community partnership in supporting purposeful initiatives. They noted that the project carries a message of hope for cancer patients and their families and embodies the values of human solidarity and social compassion.

Ibrahim Sharaf, Chairman of the Sharaf Group, and Sharafuddin Sharaf, Vice Chairman, affirmed that their involvement in this medical landmark demonstrates a firm belief that human health is the foundation of a more prosperous and stable future. The group added that the initiative represents constructive partnership between the public and private sectors, contributes to the development of advanced infrastructure that promotes medical research and innovation, and reinforces Dubai’s position as a leading global healthcare hub.

Located in Dubai Healthcare City Phase 2, the 59,000-square-meter Hamdan Bin Rashid Cancer Hospital will feature 53 clinics, 21 clinical research areas, 60 infusion rooms, 10 urgent care rooms, 5 radiotherapy rooms, and 116 inpatient beds.

Designed with sustainability in mind, the hospital will also include 19 tranquil gardens and serve as a comprehensive healthcare center providing diagnosis, treatment, and supportive care.

Athlete Ghani Souleymane has reached the halfway mark of his Guinness World Record attempt, having completed over 50 triathlons in support of Al Jalila Foundation, the philanthropic arm of Dubai Health.

The challenge supports the efforts of Al Jalila Foundation’s sports philanthropy program, which is dedicated to transforming athletic achievement into meaningful humanitarian impact. To date, and with the support of community partners, the program has raised nearly AED 15 million through more than 450 events, with every donation going directly toward patient care.

The Dubai T100 Triathlon is one of the flagship events in the global T100 series, bringing together athletes and endurance enthusiasts of all ages. Souleymane’s “T100x100” challenge is an attempt to complete 100 triathlons in 100 consecutive days, with each day requiring a 2 km swim, 80 km cycle, and 18 km run.

The Child Fund
Proceeds from Souleymane’s challenge will go directly toward providing treatment for children with cancer through Al Jalila Foundation’s The Child Fund, offering hope to young patients and their families.

Commenting on the occasion, Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “We believe that sport plays a vital role in strengthening the connection between health and community, and in inspiring individuals to become active partners in the journey of giving. Souleymane’s experience is a powerful example of how personal dedication can be directed to serve noble humanitarian causes, reinforcing the values of solidarity and compassion, and contributing to improving the quality of life for children while restoring hope to their families.”

He added: “We are confident in Souleymane’s ability to complete the challenge and reach a milestone worthy of recognition in the Guinness World Records. His achievement will serve as a powerful source of inspiration, reflecting Dubai Health’s mission to advance health for humanity.”

Highlighting the significance of the challenge, Sam Renouf, CEO of the Professional Triathletes Organisation, said: “Ghani’s T100 challenge captures the true spirit of our sport – using triathlon as a platform to inspire, unite communities and drive meaningful change. The T100 World Tour is built on stories like these, where professional racing and grassroots passion combine to leave a lasting impact well beyond the finish line. We are proud to see Dubai and the UAE leading the way with such an extraordinary effort.”

Sharing his motivation, Ghani Souleymane said: “I’m proud to support Al Jalila Foundation’s mission to use sport as a force for positive change, improving lives, promoting better health, and strengthening the values of compassion and solidarity that define the UAE community. Through this challenge, I carry a humanitarian message to stand with children battling cancer. With every step I take, I hope to turn effort into hope, and give those in need a real chance at life.”

Having reached the halfway point, Souleymane’s physical strength and determination have become a powerful source of inspiration and a wide-reaching community rallying call to support Al Jalila Foundation’s mission to fund cancer treatment for children. The challenge is set to conclude at the Dubai T100 Triathlon on November 16, 2025.

This press release is issued in Arabic, to read please refer to the Arabic page.

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, honoured the donors of the Hamdan Bin Rashid Cancer Hospital in recognition of their generosity, which is driving the construction of Dubai’s first fully integrated comprehensive cancer care facility.

The ceremony, organised by Al Jalila Foundation, the philanthropic arm of Dubai Health, took place at the construction site of the hospital in Dubai Healthcare City Phase 2. It was attended by Her Excellency Dr. Raja Easa Al Gurg, member of the Dubai Health Board of Directors, Chairperson of Al Jalila Foundation Board of Directors and Chair of the Hamdan Bin Rashid Cancer Hospital Steering Committee; Dr. Amer Sharif, CEO of Dubai Health, and Dr. Amer Al Zarooni, CEO of Al Jalila Foundation.

55 donors, representing individuals, charitable organisations and public and private entities were recognised at the ceremony.

Commitment to philanthropy
His Highness Sheikh Ahmed bin Saeed Al Maktoum affirmed that giving is deeply rooted in the UAE’s longstanding humanitarian legacy and remains a driving force behind both development and charitable work.

He said: “Guided by the vision of our leadership, the UAE continues to uphold these core values. The establishment of the Hamdan Bin Rashid Cancer Hospital reflects the principles laid down by our founding fathers, placing giving at the heart of our national responsibility.”

His Highness commended the donors’ contributions, highlighting their key role in supporting the development of this landmark facility. He emphasised the importance of sustaining this noble work, which embodies social responsibility and human solidarity, while strengthening community partnerships that advance healthcare and place people at the heart of its priorities.

Leadership perspectives
Her Excellency Dr. Raja Easa Al Gurg highlighted the significance of the hospital, saying: “This hospital embodies the vision of our leadership, which recognises human health as the nation’s true wealth. By establishing a fully integrated facility, we provide hope to patients and their families and create an advanced centre for specialised cancer care.”

She added: “We are deeply grateful to all our partners and supporters, both individuals and institutions, for their invaluable contributions, trust in our mission, and belief in advancing human health and improving quality of life.”

Dr. Amer Sharif reaffirmed that the hospital is a significant addition to Dubai’s healthcare system, providing a model that integrates medical treatment with supportive care to deliver a holistic patient experience.

He said: “The hospital will serve as both a centre for treatment and a beacon of hope for patients, offering advanced medical capabilities that meet the highest international standards. It will also act as a learning and research hub, strengthening our healthcare system by contributing to the discovery of new treatments and the development of forward-thinking approaches that improve patient outcomes and quality of life.”

Strategic partnerships
Dr. Amer Al Zarooni highlighted that Al Jalila Foundation, the philanthropic arm of Dubai Health, is responsible for raising funds to support the construction and development of the hospital through strategic partnerships with donors.

He noted that these efforts reflect the Foundation’s ongoing commitment to philanthropy, humanitarian work, and the advancement of healthcare in the UAE.

Fully integrated hospital
Located in Dubai Healthcare City Phase 2, the 59,000-square-metre Hamdan Bin Rashid Cancer Hospital pays tribute to the late Sheikh Hamdan bin Rashid Al Maktoum and his lifetime legacy of philanthropy. It will feature 53 clinics, 21 clinical research areas, 60 infusion rooms, 10 urgent care rooms, 5 radiotherapy rooms and 116 inpatient beds.

Designed with well-being in mind, the hospital will also include 19 tranquil gardens and will serve as a centre of excellence for cancer treatment and research in the region.

Dubai Health has announced the successful completion of 15 heart surgeries for patients of different ages and nationalities under the second edition of “Nabadat” campaign 2025. Led by Al Jalila Foundation, the philanthropic arm of Dubai Health, and carried out in partnership with the Mohammed bin Rashid Al Maktoum Charity Establishment, the initiative provides comprehensive care for patients with congenital and chronic heart conditions at Dubai Health hospitals.

The announcement coincides with World Heart Day, observed annually on September 29, underscoring Dubai Health’s dedication to global efforts to raise awareness of heart disease and deliver impactful healthcare programs that transform lives.

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Our partnership with the Mohammed bin Rashid Al Maktoum Charity Establishment through the Nabadat initiative reflects a shared vision to advance health for humanity. Thanks to the dedication of our teams, we are able to impact lives and offer hope for the future.”

He added: “Nabadat also exemplifies Dubai Health’s commitment to fostering the values of social solidarity and enhancing quality of life through impactful humanitarian programmes. The successful completion of this number of complex surgeries demonstrates the initiative’s expanding scope and its growing impact in enabling patients to access advanced treatment in line with the highest medical standards.”

Saleh Zaher Al Mazrouei, Director General of the Mohammed bin Rashid Al Maktoum Charity Establishment, said: “We are proud to have launched and lead the Nabadat campaign, which embodies the deeply rooted values of solidarity within our society, in collaboration with Al Jalila Foundation, the philanthropic arm of Dubai Health. This support stems from our commitment to harnessing our resources to provide healthcare for patients in need, driven by our belief that caring for people reflects the very essence of our humanitarian mission.”

He added: “Nabadat is one of the Establishment’s leading humanitarian initiatives, that helps save the lives of children and adults with congenital heart defects, offering them a healthier and more hopeful future. It also underscores the power of community partnerships in uniting efforts to create a lasting impact in healthcare.”

Dr. Obaid Mohammed Al Jassim, Consultant and Head of Cardiothoracic Surgery at Dubai Hospital and Medical Director of the Nabadat initiative, said: “All 15 surgeries were successfully completed despite their complexity, with the medical team managing challenging cases that included open-heart surgeries and catheter interventions, demonstrating the readiness and high competence of the healthcare professionals.

He further explained that Nabadat has proven successful in achieving its goals, helping to restore hope to many adults and children suffering from heart conditions. He emphasised that the continuation of these efforts reflects the initiative’s commitment to its humanitarian mission of providing patients with healthier futures.

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, officially inaugurated Dubai Health’s Center for Innovation and Technology.

The center combines clinical expertise, research, and innovative technologies to shape the future of healthcare, and advance health for humanity.

The inauguration was held as part of the Dubai Health Board of Directors meeting, chaired by His Highness Sheikh Ahmed bin Saeed Al Maktoum, and attended by Board members including Her Excellency Dr. Raja Easa Al Gurg, His Excellency Abdulla Abdul Rahman Al Shaibani, Professor Sir Ian Andrew Greer, His Excellency Walid Saeed Al Awadhi, His Excellency Mohammed Hassan Al Shehhi, and Dr. Amer Sharif, CEO of Dubai Health.

His Highness Sheikh Ahmed bin Saeed conveyed his sincere appreciation to His Excellency Professor Alawi Alsheikh-Ali, Director General of the Dubai Health Authority, for his valuable contributions to Dubai Health and for his instrumental role in laying the foundation for Dubai’s first academic health system. His Highness wished him continued success in his new responsibilities.

During the meeting, Board members reviewed key achievements and were briefed on the progress of projects aimed at enhancing patient care and elevating the quality of healthcare.

His Highness Sheikh Ahmed bin Saeed welcomed the Board members, commending their efforts to advance healthcare in alignment with Dubai’s Social Agenda 33.

His Highness stated: “We are progressing steadily toward a future where innovation and advanced technology are at the core of healthcare delivery. The Center for Innovation and Technology at Dubai Health serves as a strategic platform that brings together expertise, talent, and forward-thinking ideas to develop solutions that make a real difference in people’s health. I extend my appreciation to Dr. Raja Easa Al Gurg and Dr. Amina Al Rostamani for their generous contributions to the establishment of this pioneering center.”

Deserving recognition

His Highness honoured Dr. Raja Easa Al Gurg, Chairperson of the Easa Saleh Al Gurg Charity Foundation, and Dr. Amina Al Rostamani, Board member at the AW Rostamani Group, in recognition of their support in establishing Dubai Health’s Center for Innovation and Technology. His Highness expressed his sincere appreciation for their valuable community efforts in advancing care, medical education, and research.

The Dubai Health Board of Directors also expressed their gratitude to Her Excellency Dr. Raja Easa Al Gurg and Her Excellency Dr. Amina Al Rostamani for their generous contributions to the Center for Innovation and Technology and commended their well-deserved recognition for their pivotal role in advancing community philanthropy.

Her Excellency Dr. Raja Easa Al Gurg thanked His Highness Sheikh Ahmed bin Saeed for the honour, noting that supporting such initiatives builds on the values instilled by her late father, whose contributions left a lasting mark on community service and the spirit of giving. She emphasised that the establishment of the center will foster innovation and continuous development in the healthcare system by enabling research teams to advance and adopt emerging technologies.

Her Excellency Dr. Amina Al Rostamani expressed her pride in being honoured by His Highness Sheikh Ahmed bin Saeed. She said: “I am privileged to have contributed to the establishment of the Center for Innovation and Technology at Dubai Health, which aims to accelerate the adoption of smart solutions in healthcare and strengthen Dubai’s position in medical sciences through strategic partnerships. Social responsibility is deeply rooted in our community and remains an essential driver of the sustainable development led by our wise leadership.”

His Highness Sheikh Ahmed bin Saeed toured the Center for Innovation and Technology in the company of Her Excellency Dr. Raja Easa Al Gurg and Her Excellency Dr. Amina Al Rostamani, the center’s primary benefactors, as well as members of the Dubai Health Board of Directors. They were joined by Peter Hall, President of IMEA at Informa Markets, and Hal Wolf, President and CEO of HIMSS. During the visit, His Highness was briefed on the latest innovative projects designed to enhance the quality of care.

Strategic partnerships

The Center for Innovation and Technology was established through the generous contributions of the Easa Saleh Al Gurg Charity Foundation and the AW Rostamani Group, which made a joint donation of AED10 million through Al Jalila Foundation, the philanthropic arm of Dubai Health.

The center’s launch coincides with the first edition of WHX Tech 2025, the Global Health Technology Exhibition, taking place from 8–10 September 2025 at the Dubai World Trade Centre. During the event, Dubai Health will announce a series of new collaborations with leading academic, technology, and government partners to advance projects at the center. These partnerships include Dubai Future Foundation, Prototypes for Humanity, Dubai Institute of Design and Innovation, Siemens Healthineers, Schneider Electric, and Huawei.

The Center for Innovation and Technology is committed to transforming bold ideas into real-world solutions that enhance patient care, drive medical advancements, and improve lives, in line with Dubai Health’s ‘Patient First’ promise. It also serves as an educational and research platform, enabling clinicians, scientists, learners, and innovators to pioneer breakthroughs that shape the future of healthcare.

Dr. Yacine Hadjiat, Director of The Center for Innovation and Technology at Dubai Health, said: “The Center for Innovation and Technology brings together talent from across disciplines, and provides the environment and resources needed to reimagine healthcare delivery. It is designed not only to advance technology but also to inspire bold thinking, foster collaboration, and accelerate discoveries that ultimately serve patients and improve lives.”

Designed in line with the world’s leading health innovation hubs, the center houses advanced laboratories and technologies for developing, testing and validating solutions. This includes the Extended Reality and Brain Interface Lab (XR BCI), the Robotics and Sensors Lab, Artificial Intelligence and Data Lab, Design Lab, a User Experience Room, and spaces for collaboration.

To support the transition from discovery to application, the center also offers comprehensive services through its Technology Transfer Office (TTO), enabling innovators to protect intellectual property and build partnerships.